First Horizon Corporation’s Vertex Pharmaceuticals VRTX Stock Holding History

First Horizon Corporation’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.56M	Sell	11,201 -3,334	-23%	-$1.48M	0.21%	117
2026 Q1	$6.49M	Buy	14,535 +2,380	+20%	+$1.11M	0.27%	106
2025 Q4	$5.51M	Sell	12,155 -1,966	-14%	-$847K	0.25%	104
2025 Q3	$5.53M	Buy	+14,121	New	+$5.9M	0.26%	106
2021 Q2	$20K	Sell	102 -10	-9%	-$2.09K	﹤0.01%	551
2021 Q1	$24K	Buy	112 +23	+26%	+$5.05K	﹤0.01%	510
2020 Q4	$21K	Sell	89 -26	-23%	-$5.96K	﹤0.01%	513
2020 Q3	$31K	Buy	+115	New	+$31.7K	﹤0.01%	410

Other funds holding VRTX

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

BHIA

Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return

CTB

Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

GIA

Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return

IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return

First Horizon Corporation's VRTX Position: Q2 2026 in Review

First Horizon Corporation reduced its Vertex Pharmaceuticals (VRTX) stake by 23% in Q2 2026, selling an estimated $1.48M and leaving 11,201 shares worth $5.56M. The position accounts for 0.21% of the portfolio, ranked #117.

First Horizon Corporation first reported a position in VRTX in Q3 2020 and has held it in 8 quarters since. The position peaked at $6.49M in Q1 2026. 334 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

First Horizon Corporation held 11,201 shares of Vertex Pharmaceuticals worth $5.56M as of Q2 2026.
First Horizon Corporation sold 3,334 Vertex Pharmaceuticals shares in Q2 2026, an estimated $1.48M.
Vertex Pharmaceuticals made up 0.21% of First Horizon Corporation's portfolio in Q2 2026, its #117 holding.
First Horizon Corporation first reported a position in Vertex Pharmaceuticals in Q3 2020 and has held it in 8 quarters since.
First Horizon Corporation's Vertex Pharmaceuticals position peaked at $6.49M in Q1 2026.
334 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on First Horizon Corporation's 13F filing for Q2 2026, filed 20 Jul 2026.